| 摘要 |
I kappa B- beta polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing I kappa B- beta polypeptides and polynucleotides in the design of protocols for the treatment of inflammatory conditions including but not limited to rheumatoid arthritis, dermatosis (eg. psoriasis), inflammatory bowel disease, autoimmune diseases, tissue and/or organ rejection, Alzheimer's disease, stroke, atherosclerosis, restenosis, cancer, viral infection including but not limited to AIDS, osteoarthritis, osteoperosis, and Ataxia Telangiestasia, among others, and diagnostic assays for such conditions. |
